PUBLISHER: Renub Research | PRODUCT CODE: 1422478
PUBLISHER: Renub Research | PRODUCT CODE: 1422478
Viscosupplementation Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
Global Viscosupplementation market size is projected to reach US$ 7.81 Billion by 2030, as per Renub Research. Hyaluronic acid (HA) injections are typically used for treating localized osteoarthritis (OA) due to their easy application and tolerability. Many HA derivatives are available, with various properties and ranges of proof. Viscosupplementation is moderately but appreciably effective in reducing pain and improving feature in comparison to a placebo. It has a high rate of positive responses while used to treat knee osteoarthritis. It can help lessen the need for opioid analgesics and NSAIDs, ensuing in an improved risk/gain ratio, and might additionally put off the need for joint replacement.
The prevalence of age-related illnesses is increasing with the arena's growing older populace, with osteoarthritis being the maximum commonplace joint disorder. Osteoarthritis is related to excessive scientific and social changes. Viscosupplementation, which involves injecting hyaluronic acid derivatives into the joint, is becoming a more famous remedy method. The materials applied in this procedure are high molecular-weight polysaccharides. These distribute weight, lubricate the joint and exhibit anti-inflammatoryproperties. Additionally, those drugs exert physical-chemical outcomes on various joint characteristics. The importance of those results is contingent upon the molecular weight and attention of the drug, alongside the presence of any cross-links within the drug.
Viscosupplementation Market is expected to grow at a compound annual growth rate (CAGR) of 8.97% from 2024 to 2030
Viscosupplementation, an outpatient procedure, effectively alleviates pain and enhances joint function in osteoarthritis patients. It contributes to the augmentation of joint cartilage in terms of quality and quantity. With a commendable safety record and cost-effectiveness, this procedure is often recommended post-arthroscopy. Knee and hip osteoarthritis prevalence is rising among older people due to age-related factors impacting cartilage strength and flexibility. The aging population, expected to double to 1.5 billion by 2050, is a global trend reported by the United Nations. By 2043, seniors constituted about 25% of Canada's total population, as per government statistics.
The viscosupplementation market is expanding, propelled by the widespread adoption of key strategies like collaboration, acquisition, agreements, and company partnerships. A primary growth driver is the increasing prevalence of osteoporosis and osteoarthritis (OA). This has led to heightened adoption of viscosupplementation in the healthcare sector for managing joint pain-an appealing, minimally invasive alternative to corticosteroids. The market benefits significantly from this shift. Moreover, consumer awareness of the advantages of non-surgical treatments, including cost-effectiveness, absence of hospitalization, minimal complications, and improved clinical outcomes, amplifies this trend, further fueling the market's growth.
Favorable government policies and substantial investments by pharmaceutical companies in novel drugs and alternative administration routes propel growth in the healthcare industry. This expansion is bolstered by the emergence of ambulatory surgical centers (ACS), addressing surgical and non-surgical issues in joints, ligaments, muscles, spine, and nerves. The market receives an additional boost from introducing open-label single-injections with hyaluronic acid, actively driving industry growth.
The viscosupplementation market is experiencing positive impacts from factors like favorable health insurance reimbursement policies, a growing population with chronic disabilities, and an increasing geriatric demographic susceptible to chronic ailments. Collaborations, partnerships, and continuous research and development (R&D) activities in the medical sciences further contribute to this growth. In 2023, the viscosupplementation market reached a valuation of US$ 4.28 Billion.
Segment of single-injection viscosupplementation is anticipated to experience growth in the future
The Viscosupplementation market is segmented by Product into Single Injection, Three Injection, and Five Injection. The single-injection viscosupplementation segment is poised for substantial growth in the coming years. This anticipated expansion is attributed to several factors:
- 1. The single-injection approach provides enhanced convenience for both physicians and patients.
- 2. There is a rising demand for outpatient surgeries, particularly those emphasizing same-day surgical care, encompassing preventive and diagnostic procedures.
- 3. Companies are intensifying their efforts to develop single-injection treatments for osteoarthritis, resulting in increased product launches.
The growing focus on offering efficient solutions for osteoarthritis patients aligns with the overall strategy of developing single-injection products, contributing to the anticipated growth of the viscosupplementation market throughout the forecast period.
Knee osteoarthritis emerged as the dominant force in the viscosupplementation market
By application, the Viscosupplementation market is divided into Knee, Hip, Hand/Wrist, Ankle/Foot, and Others. The knee osteoarthritis segment has asserted its dominance in the viscosupplementation market, primarily fueled by the escalating prevalence of knee osteoarthritis and the increasing geriatric population, which is more prone to this condition. The aging demographic is particularly susceptible to knee osteoarthritis due to the aging process, leading to a reduction in the water content of cartilage. This diminishes its capacity to absorb shock and provide cushioning, making older people more susceptible to knee-related ailments. The significant prevalence of knee osteoarthritis and its correlation with age underscore the prominence of this segment within the viscosupplementation market.
Orthopedic clinics/Ambulatory Surgical Centers market is rising year on year
By End User, the Viscosupplementation market is classified into Hospitals and orthopedic clinics/Ambulatory Surgical Centers. The orthopedic clinics and ambulatory surgical centers market is witnessing consistent annual growth. This trend indicates the increasing demand for specialized orthopedic services and the adoption of outpatient surgical procedures. Patients increasingly prefer these facilities for convenience, efficient services, and reduced hospitalization time. Additionally, advancements in medical technology and the emphasis on providing comprehensive orthopedic care contribute to the sustained expansion of this market. As healthcare continues to evolve towards more patient-centric models, the growth of orthopedic clinics and ambulatory surgical centers reflects the changing landscape of orthopedic healthcare services.
China will be the second-largest contributor to the market
By Countries, Viscosupplementation market is split into North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey, Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand), South America (Brazil, Mexico, Argentina), Middle East & Africa (South Africa, Saudi Arabia, UAE). The expansion of the viscosupplementation market in China is influenced by diverse factors such as population demographics, disease incidence, prevalence, macroeconomic conditions, and geopolitical considerations. Market fluctuations may arise from unexpected shifts in these elements and alterations in clinical practices that result in modifications to patient diagnosis or treatment approaches, reflecting a broader effort to enhance overall medical practices.
The U.S. viscosupplementation market is growing due to a rising osteoarthritis population seeking non-surgical solutions. As per the CDC, about 34.5 million Americans contend with osteoarthritis annually, marked by reduced hyaluronic acid leading to pain and stiffness. Increased interest in non-surgical options, driven by concerns over surgery and treatment costs, contributes to market growth. Ongoing advancements in hyaluronic acid therapies, tailored by key players for swift knee pain relief, further propel the market. Researchers are also exploring diverse strategies to impede the progression of knee pain disorders amidst this growth trend.
Key Player
Anika Therapeutics Inc., Zimmer Biomet, Smith & Nephew PLC, F.Hoffmann-La Roche Ltd, Sanofi, Chugai Pharmaceutical Co., Lifecore Biomedical, and LG Life Sciences Ltd are the leading companies in the Viscosupplementation market.
Renub Research latest report "Global Viscosupplementation Market Forecast by Product (Single Injection Viscosupplementation, Three Injections Viscosupplementation and Five Injections Viscosupplementation), By Application (Knee, Hip, Hand/Wrist, Ankle/Foot, and Others), by End User (Hospitals, Orthopedic Clinics/Ambulatory Surgical Centres), By Region (North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey, Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand), South America (Brazil, Mexico, Argentina), Middle East & Africa (South Africa, Saudi Arabia, UAE)), Key Players Analysis (Anika Therapeutics Inc, Zimmer Biomet, Smith & Nephew PLC, F.Hoffmann-La Roche Ltd, Sanofi, Chugai Pharmaceutical Co, Lifecore Biomedical and LG Life Sciences Ltd)" provides a detailed analysis of Global Viscosupplementation Industry.
Product - Market have been covered from 3 viewpoints
- 1. Single Injection Viscosupplementation
- 2. Three Injections Viscosupplementation
- 3. Five Injections Viscosupplementation
Application - Market have been covered from 5 viewpoints
- 1. Knee
- 2. Hip
- 3. Hand/Wrist
- 4. Ankle/Foot
- 5. Others
End User - Market have been covered from 2 viewpoints
- 1. Hospitals
- 2. Orthopedic clinics/Ambulatory Surgical Centers
Region - Market have been covered from 25 Countries viewpoints
- 1. North America
- 1.1. United States
- 1.2. Canada
- 2. Europe
- 2.1. France
- 2.2. Germany
- 2.3. Italy
- 2.4. Spain
- 2.5. United Kingdom
- 2.6. Belgium
- 2.7. Netherlands
- 2.8. Turkey
- 3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. South Korea
- 3.5. Thailand
- 3.6. Malaysia
- 3.7. Indonesia
- 3.8. Australia
- 3.9. New Zealand
- 4. Latin America
- 4.1. Brazil
- 4.2. Mexico
- 4.3. Argentina
- 5. Middle East & Africa
- 5.1. Saudi Arabia
- 5.2. United Arab Emirates
- 5.3. South Africa
Company Analysis
- Overview
- Recent Development
- Revenue
Companies Covered
- 1. Anika Therapeutics Inc
- 2. Zimmer Biomet
- 3. Smith & Nephew PLC
- 4. F.Hoffmann-La Roche Ltd
- 5. Sanofi
- 6. Chugai Pharmaceutical Co
- 7. Lifecore Biomedical
- 8. LG Life Sciences Ltd
Table of Contents
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
- 4.1 Growth Drivers
- 4.2 Challenges
5. Global Viscosupplementation Market
6. Market Share - Global Viscosupplementation Market
- 6.1 By Product
- 6.2 By Application
- 6.3 By End User
- 6.4 By Countries
7. Product - Global Viscosupplementation Market
- 7.1 Single Injection
- 7.2 Three Injection
- 7.3 Five Injection
8. Application - Global Viscosupplementation Market
- 8.1 Knee Osteoarthritis
- 8.2 Hip Osteoarthritis
- 8.3 Hand/Wrist Osteoarthritis
- 8.4 Ankle/Foot Osteoarthritis
- 8.5 Others
9. End User - Global Viscosupplementation Market
- 9.1 Hospitals
- 9.2 Orthopedic clinics/Ambulatory Surgical Centers
10. Countries - Global Viscosupplementation Market
- 10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.2 Europe
- 10.2.1 France
- 10.2.2 Germany
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Belgium
- 10.2.7 Netherlands
- 10.2.8 Turkey
- 10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Thailand
- 10.3.6 Malaysia
- 10.3.7 Indonesia
- 10.3.8 Australia
- 10.3.9 New Zealand
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.2 Mexico
- 10.4.3 Argentina
- 10.5 Middle East & Africa
- 10.5.1 Saudi Arabia
- 10.5.2 United Arab Emirates
- 10.5.3 South Africa
11. Porter's Five Forces - Global Viscosupplementation Market
- 11.1 Bargaining Power of Buyer
- 11.2 Bargaining Power of Supplier
- 11.3 Threat of New Entrants
- 11.4 Rivalry among Existing Competitors
- 11.5 Threat of Substitute Products
12. SWOT Analysis - Global Viscosupplementation Market
- 12.1 Strengths
- 12.2 Weaknesses
- 12.3 Opportunities
- 12.4 Threats
13. Key Players Analysis
- 13.1 Anika Therapeutics, Inc.
- 13.1.1 Company overview
- 13.1.2 Recent Development
- 13.1.3 Sales Analysis
- 13.2 Zimmer Biomet
- 13.2.1 Company overview
- 13.2.2 Recent Development
- 13.2.3 Sales Analysis
- 13.3 Smith & Nephew PLC
- 13.3.1 Company overview
- 13.3.2 Recent Development
- 13.3.3 Sales Analysis
- 13.4 F.Hoffmann-La Roche Ltd.
- 13.4.1 Company overview
- 13.4.2 Recent Development
- 13.4.3 Sales Analysis
- 13.5 Sanofi
- 13.5.1 Company overview
- 13.5.2 Recent Development
- 13.5.3 Sales Analysis
- 13.6 Chugai Pharmaceutical Co.
- 13.6.1 Company overview
- 13.6.2 Recent Development
- 13.6.3 Sales Analysis
- 13.7 Lifecore Biomedical
- 13.7.1 Company overview
- 13.7.2 Recent Development
- 13.7.3 Sales Analysis
- 13.8 LG Life Sciences Ltd.
- 13.8.1 Company overview
- 13.8.2 Recent Development
- 13.8.3 Sales Analysis
List of Figures
- Figure-01: Global - Viscosupplementation Market (Billion US$), 2018 - 2023
- Figure-02: Global - Forecast for Viscosupplementation Market (Billion US$), 2024 - 2030
- Figure-03: Product - Single Injection Market (Million US$), 2018 - 2023
- Figure-04: Product - Forecast for Single Injection Market (Million US$), 2024 - 2030
- Figure-05: Product - Three Injection Market (Million US$), 2018 - 2023
- Figure-06: Product - Forecast for Three Injection Market (Million US$), 2024 - 2030
- Figure-07: Product - Five Injection Market (Million US$), 2018 - 2023
- Figure-08: Product - Forecast for Five Injection Market (Million US$), 2024 - 2030
- Figure-09: Application - Knee Osteoarthritis Market (Million US$), 2018 - 2023
- Figure-10: Application - Forecast for Knee Osteoarthritis Market (Million US$), 2024 - 2030
- Figure-11: Application - Hip Osteoarthritis Market (Million US$), 2018 - 2023
- Figure-12: Application - Forecast for Hip Osteoarthritis Market (Million US$), 2024 - 2030
- Figure-13: Application - Hand/Wrist Osteoarthritis Market (Million US$), 2018 - 2023
- Figure-14: Application - Forecast for Hand/Wrist Osteoarthritis Market (Million US$), 2024 - 2030
- Figure-15: Application - Ankle/Foot Osteoarthritis Market (Million US$), 2018 - 2023
- Figure-16: Application - Forecast for Ankle/Foot Osteoarthritis Market (Million US$), 2024 - 2030
- Figure-17: Application - Others Market (Million US$), 2018 - 2023
- Figure-18: Application - Forecast for Others Market (Million US$), 2024 - 2030
- Figure-19: End User - Hospitals Market (Million US$), 2018 - 2023
- Figure-20: End User - Forecast for Hospitals Market (Million US$), 2024 - 2030
- Figure-21: End User - Orthopedic clinics/Ambulatory Surgical Centers Market (Million US$), 2018 - 2023
- Figure-22: End User - Forecast for Orthopedic clinics/Ambulatory Surgical Centers Market (Million US$), 2024 - 2030
- Figure-23: United States - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-24: United States - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-25: Canada - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-26: Canada - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-27: France - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-28: France - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-29: Germany - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-30: Germany - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-31: Italy - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-32: Italy - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-33: Spain - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-34: Spain - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-35: United Kingdom - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-36: United Kingdom - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-37: Belgium - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-38: Belgium - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-39: Netherlands - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-40: Netherlands - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-41: Turkey - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-42: Turkey - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-43: China - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-44: China - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-45: Japan - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-46: Japan - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-47: India - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-48: India - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-49: South Korea - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-50: South Korea - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-51: Thailand - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-52: Thailand - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-53: Malaysia - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-54: Malaysia - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-55: Indonesia - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-56: Indonesia - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-57: Australia - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-58: Australia - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-59: New Zealand - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-60: New Zealand - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-61: Brazil - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-62: Brazil - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-63: Mexico - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-64: Mexico - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-65: Argentina - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-66: Argentina - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-67: Saudi Arabia - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-68: Saudi Arabia - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-69: United Arab Emirates - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-70: United Arab Emirates - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-71: South Africa - Viscosupplementation Market (Million US$), 2018 - 2023
- Figure-72: South Africa - Forecast for Viscosupplementation Market (Million US$), 2024 - 2030
- Figure-73: Anika Therapeutics, Inc. - Global Revenue (Million US$), 2018 - 2023
- Figure-74: Anika Therapeutics, Inc. - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-75: Zimmer Biomet - Global Revenue (Million US$), 2018 - 2023
- Figure-76: Zimmer Biomet - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-77: Smith & Nephew PLC - Global Revenue (Million US$), 2018 - 2023
- Figure-78: Smith & Nephew PLC - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-79: F.Hoffmann-La Roche Ltd. - Global Revenue (Million US$), 2018 - 2023
- Figure-80: F.Hoffmann-La Roche Ltd. - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-81: Sanofi - Global Revenue (Million US$), 2018 - 2023
- Figure-82: Sanofi - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-83: Chugai Pharmaceutical Co. - Global Revenue (Million US$), 2018 - 2023
- Figure-84: Chugai Pharmaceutical Co. - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-85: Lifecore Biomedical - Global Revenue (Million US$), 2018 - 2023
- Figure-86: Lifecore Biomedical - Forecast for Global Revenue (Million US$), 2024 - 2030
- Figure-87: LG Life Sciences Ltd. - Global Revenue (Million US$), 2018 - 2023
- Figure-88: LG Life Sciences Ltd. - Forecast for Global Revenue (Million US$), 2024 - 2030
List of Tables
- Table-01: Global - Viscosupplementation Market Share by Product (Percent), 2018 - 2023
- Table-02: Global - Forecast for Global Viscosupplementation Market Share by Product (Percent), 2024 - 2030
- Table-03: Global - Viscosupplementation Market Share by Category (Percent), 2018 - 2023
- Table-04: Global - Forecast for Global Viscosupplementation Market Share by Category (Percent), 2024 - 2030
- Table-05: Global - Viscosupplementation Market Share by Type (Percent), 2018 - 2023
- Table-06: Global - Forecast for Global Viscosupplementation Market Share by Type (Percent), 2024 - 2030
- Table-07: Global - Viscosupplementation Market Share by Countries (Percent), 2018 - 2023
- Table-08: Global - Forecast for Global Viscosupplementation Market Share by Countries (Percent), 2024 - 2030
